122 related articles for article (PubMed ID: 37717265)
1. Osteosarcoma's genetic landscape painted by genes' mutations.
Urban W; Krzystańska D; Piekarz M; Nazar J; Jankowska A
Acta Biochim Pol; 2023 Sep; 70(3):671-678. PubMed ID: 37717265
[TBL] [Abstract][Full Text] [Related]
2. The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma.
Liu W; Cheng H; Huang Z; Li Y; Zhang Y; Yang Y; Jin T; Sun Y; Deng Z; Zhang Q; Lou F; Cao S; Wang H; Niu X
Mol Oncol; 2024 Apr; 18(4):939-955. PubMed ID: 37727135
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population.
Ru JY; Cong Y; Kang WB; Yu L; Guo T; Zhao JN
Int J Clin Exp Pathol; 2015; 8(3):3198-203. PubMed ID: 26045840
[TBL] [Abstract][Full Text] [Related]
4. Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas.
Liang X; Li Q; Xu B; Hu S; Wang Q; Li Y; Zong Y; Zhang S; Li C
Int J Clin Oncol; 2019 Sep; 24(9):1061-1068. PubMed ID: 31065835
[TBL] [Abstract][Full Text] [Related]
5. Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.
Cleven AH; Höcker S; Briaire-de Bruijn I; Szuhai K; Cleton-Jansen AM; Bovée JV
Am J Surg Pathol; 2015 Nov; 39(11):1576-83. PubMed ID: 26457357
[TBL] [Abstract][Full Text] [Related]
6. High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenes.
Choy E; Hornicek F; MacConaill L; Harmon D; Tariq Z; Garraway L; Duan Z
Cancer; 2012 Jun; 118(11):2905-14. PubMed ID: 22006429
[TBL] [Abstract][Full Text] [Related]
7. DNA damage response and repair in osteosarcoma: Defects, regulation and therapeutic implications.
Sadoughi F; Maleki Dana P; Asemi Z; Yousefi B
DNA Repair (Amst); 2021 Jun; 102():103105. PubMed ID: 33836418
[TBL] [Abstract][Full Text] [Related]
8. ARID3A regulates autophagy related gene BECN1 expression and inhibits proliferation of osteosarcoma cells.
Parlayan C; Sahin Y; Altan Z; Arman K; Ikeda MA; Saadat KASM
Biochem Biophys Res Commun; 2021 Dec; 585():89-95. PubMed ID: 34801937
[TBL] [Abstract][Full Text] [Related]
9. Germ-line genetic variation of TP53 in osteosarcoma.
Savage SA; Burdett L; Troisi R; Douglass C; Hoover RN; Chanock SJ;
Pediatr Blood Cancer; 2007 Jul; 49(1):28-33. PubMed ID: 17096406
[TBL] [Abstract][Full Text] [Related]
10. How microRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation.
Poos K; Smida J; Nathrath M; Maugg D; Baumhoer D; Korsching E
PLoS Comput Biol; 2013; 9(8):e1003210. PubMed ID: 24009496
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.
Selvarajah GT; Kirpensteijn J; van Wolferen ME; Rao NA; Fieten H; Mol JA
Mol Cancer; 2009 Sep; 8():72. PubMed ID: 19735553
[TBL] [Abstract][Full Text] [Related]
12. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer.
Liang X; Gao X; Wang F; Li S; Zhou Y; Guo P; Meng Y; Lu T
Cancer Med; 2023 Jul; 12(13):14171-14182. PubMed ID: 37184108
[TBL] [Abstract][Full Text] [Related]
14. KRAS and DAXX/ATRX gene mutations are correlated with the clinicopathological features, advanced diseases, and poor prognosis in Chinese patients with pancreatic neuroendocrine tumors.
Yuan F; Shi M; Ji J; Shi H; Zhou C; Yu Y; Liu B; Zhu Z; Zhang J
Int J Biol Sci; 2014; 10(9):957-65. PubMed ID: 25210493
[TBL] [Abstract][Full Text] [Related]
15. Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma.
Negri GL; Grande BM; Delaidelli A; El-Naggar A; Cochrane D; Lau CC; Triche TJ; Moore RA; Jones SJ; Montpetit A; Marra MA; Malkin D; Morin RD; Sorensen PH
J Pathol; 2019 Nov; 249(3):319-331. PubMed ID: 31236944
[TBL] [Abstract][Full Text] [Related]
16. Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12.
Mäkinen N; Aavikko M; Heikkinen T; Taipale M; Taipale J; Koivisto-Korander R; Bützow R; Vahteristo P
PLoS Genet; 2016 Feb; 12(2):e1005850. PubMed ID: 26891131
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of miR-1258 inhibits cell proliferation by targeting AKT3 in osteosarcoma.
Liu W; Zhou Z; Zhang Q; Rong Y; Li L; Luo Y; Wang J; Yin G; Lv C; Cai W
Biochem Biophys Res Commun; 2019 Mar; 510(3):479-486. PubMed ID: 30737029
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of the G1 to S-phase cell cycle checkpoint is involved in the pathogenesis of human osteosarcoma.
López-Guerrero JA; López-Ginés C; Pellín A; Carda C; Llombart-Bosch A
Diagn Mol Pathol; 2004 Jun; 13(2):81-91. PubMed ID: 15167009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]